1. Biotransformation of Betulonic Acid by the Fungus Rhizopus arrhizus CGMCC 3.868 and Antineuroinflammatory Activity of the Biotransformation Products
- Author
-
Chu Chengjiao, Guangtong Chen, You-Jia Lu, Bo-Yi Fan, Huilian Huang, Yan-Ni Wu, and Song Kainan
- Subjects
Pharmacology ,chemistry.chemical_classification ,Addition reaction ,Glycosylation ,biology ,Double bond ,Organic Chemistry ,Pharmaceutical Science ,Substrate (chemistry) ,biology.organism_classification ,Analytical Chemistry ,Hydroxylation ,chemistry.chemical_compound ,Complementary and alternative medicine ,chemistry ,Biotransformation ,Acetylation ,Drug Discovery ,Molecular Medicine ,Organic chemistry ,Rhizopus arrhizus - Abstract
Biotransformation of betulonic acid (1) by Rhizopus arrhizus CGMCC 3.868 resulted in the production of 16 new (3, 5, 6, and 9-21) and five known compounds. Structures of the new compounds were established by analysis of spectroscopic data. Hydroxylation, acetylation, oxygenation, glycosylation, and addition reactions involved the C-20-C-29 double bond. Antineuroinflammatory activities of the obtained compounds in NO production were tested in lipopolysaccharides-induced BV-2 cells. Compared with the substrate betulonic acid, biotransformation products 3, 8, 9, 14, and 21 exhibited an improved inhibitory effect, with IC50 values of 10.26, 11.09, 5.38, 1.55, and 4.69 μM, lower than that of the positive control, NG-monomethyl-l-arginine.
- Published
- 2021
- Full Text
- View/download PDF